Abstract: A polymorph, a polymorph screening system, and a polymorph preparing and screening method are disclosed. The polymorph preparing and screening method includes the following steps: providing a plurality of substrates of different materials; causing an organic material to grow crystals on the plurality of substrates through solution-cooling crystallization process, so that a plurality of polymorphs with different characteristics are prepared; and screening the plurality of polymorphs prepared in the previous step to obtain polymorphs with desired characteristics.

Abstract: The present invention discloses a co-crystal compound of optical devices. The co-crystal compound is crystallized out with hydrogen bonding by a temperature fluctuation method after mixing small organic molecules without optoelectronic properties and organic molecules having heterocyclic rings with optoelectronic properties. The photoluminescence (PL) intensity of this hydrogen-bonded co-crystal compound according to the present invention can vary with a variety of the small organic molecules without optoelectronic properties, so as to modulate the PL intensity.

Abstract: The present invention provides a system and a method of detecting a sublimation point, preferably applied to organic molecules. The system of detecting a sublimation point comprises: a heater, a capillary device, a vacuum pump, an ultraviolet light source, a photography device, a digital vacuum meter and a needle valve. The system of detecting a sublimation point is suitable for detecting the sublimation point of an organic light emitting molecule such as tris(8-hydroxyquinolinato) aluminum (Alq3) and tris(phenylpyridine) iridium (Ir(ppy)3). The needle valve can be used for controlling air pressure to measure the sublimation point under different pressures. Advantageously, the required quantity of organic molecules can be below 1 mg, thus not only saving the organic molecules, but also detecting the sublimation point without contaminating apparatuses.

Abstract: A method of establishing a database of gas molecules is disclosed. In this method, a metal-organic framework absorbs gas molecules of a guest material. Thereafter, after a predetermined time, the thermogravimetric analyzer (TGA) is utilized to make sure that the gas molecules have been adsorbed by the metal-organic framework. Finally, the metal organic framework with the gas molecules adsorbed thereon is analyzed by fluorescence spectrophotometer, and the light-emitting wavelength and waveform are recorded to establish a database of gas molecules.

Abstract: A sucrose of a conformational polymorph and its manufacturing method are disclosed. The sucrose is a Form II sucrose having a melting point of 140-180° C., and furfuryl alcohol is added into a saturated sucrose solution by a reverse solution method, such that the saturated solution is recrystallized to form a new sucrose. The sucrose of this conformational polymorph has a melting point lower than the melting point of a general Form I sucrose, and the solubility of the Form II sucrose is different from the solubility of the Form I sucrose. Thus the Form II sucrose can be used as an excipient of medicines, sacrificial fiber blood vessel network structure for cell cultivations, or the manufacture of an optical interference wavy device. Since the hydrogen bonds in the molecular structure of the Form II sucrose and the Form I sucrose are different, the mechanoluminescence of the sucrose is affected.

Abstract: The present invention discloses a manufacturing method for an optical device having a solvate, comprising the following steps: providing a substrate, depositing a solute on the substrate, and placing the substrate in the vapor environment of a solvent such that the solvent and the solute on the substrate form a solvate exhibiting optical properties. Furthermore, the present invention provides an optical device having a solvate, which modulates the photoluminescence (PL) intensity of the optical device via the solvate. The optical device is obtained by means of the above-described manufacturing method.

Abstract: A new sucrose is obtained through the present invention. The new sucrose has a lower solubility and a lower melting point. Thus, the new sucrose has a higher stability. The new sucrose obtained through the present invention can be used as an added functionality excipient of drug in pharmaceutical industry. And the new sucrose can also be used in sugar and food industries.

Abstract: The present invention fabricates mesocrystals of organic and organo-metallic compounds. Supersaturated solutions are made with different sums of an organic or organo-metallic compound and the organic or organo-metallic compound is added with an excipient. Through a water bath, mesocrystals are obtained from the supersaturated solutions with well-faceted nucleation and growth. Different polymorphisms are induced with different ratios of enantiomers. And the dissolution rate for fabricating the API is enhanced.

Abstract: A polymorph, a polymorph screening system, and a polymorph preparing and screening method are disclosed. The polymorph preparing and screening method includes the following steps: providing a plurality of substrates of different materials; causing an organic material to grow crystals on the plurality of substrates through solution-cooling crystallization process, so that a plurality of polymorphs with different characteristics are prepared; and screening the plurality of polymorphs prepared in the previous step to obtain polymorphs with desired characteristics.

Abstract: An organo-optoelectronic nanowire is fabricated. It is made through a one-step unit operation under a low temperature. An organo-optoelectronic template is obtained for the fabrication, whose idea is a bio-inspired one. The nanowire obtained has a high efficiency and a high surface area; and, heat generated on operation is easily emitted. Thus, the method has great potential for future use on optoelectronic devices.

Abstract: The present invention discloses a co-crystal compound of optical devices. The co-crystal compound is crystallized out with hydrogen bonding by a temperature fluctuation method after mixing small organic molecules without optoelectronic properties and organic molecules having heterocyclic rings with optoelectronic properties. The photoluminescence (PL) intensity of this hydrogen-bonded co-crystal compound according to the present invention can vary with a variety of the small organic molecules without optoelectronic properties, so as to modulate the PL intensity.

Abstract: A new sucrose is obtained through the present invention. The new sucrose has a lower solubility and a lower melting point. Thus, the new sucrose has a higher stability. The new sucrose obtained through the present invention can be used as an added functionality excipient of drug in pharmaceutical industry. And the new sucrose can also be used in sugar and food industries.

Abstract: A sucrose of a conformational polymorph and its manufacturing method are disclosed. The sucrose is a Form II sucrose having a melting point of 140-180° C., and furfuryl alcohol is added into a saturated sucrose solution by a reverse solution method, such that the saturated solution is recrystallized to form a new sucrose. The sucrose of this conformational polymorph has a melting point lower than the melting point of a general Form I sucrose, and the solubility of the Form II sucrose is different from the solubility of the Form I sucrose. Thus the Form II sucrose can be used as an excipient of medicines, sacrificial fiber blood vessel network structure for cell cultivations, or the manufacture of an optical interference wavy device. Since the hydrogen bonds in the molecular structure of the Form II sucrose and the Form I sucrose are different, the mechanoluminescence of the sucrose is affected.

Abstract: A polymorph, a polymorph screening system, and a polymorph preparing and screening method are disclosed. The polymorph preparing and screening method includes the following steps: providing a plurality of substrates of different materials; causing an organic material to grow crystals on the plurality of substrates through solution-cooling crystallization process, so that a plurality of polymorphs with different characteristics are prepared; and screening the plurality of polymorphs prepared in the previous step to obtain polymorphs with desired characteristics.

Abstract: The present invention discloses a manufacturing method for an optical device having a solvate, comprising the following steps: providing a substrate, depositing a solute on the substrate, and placing the substrate in the vapor environment of a solvent such that the solvent and the solute on the substrate form a solvate exhibiting optical properties. Furthermore, the present invention provides an optical device having a solvate, which modulates the photoluminescence (PL) intensity of the optical device via the solvate. The optical device is obtained by means of the above-described manufacturing method.

Abstract: An organo-optoelectronic nanowire is fabricated. It is made through a one-step unit operation under a low temperature. An organo-optoelectronic template is obtained for the fabrication, whose idea is a bio-inspired one. The nanowire obtained has a high efficiency and a high surface area; and, heat generated on operation is easily emitted. Thus, the present invention has a great potential for future use on optoelectronic devices.

Abstract: The present invention fabricates mesocrystals of organic and organo-metallic compounds. Supersaturated solutions are made with different sums of an organic or organo-metallic compound and the organic or organo-metallic compound is added with an excipient. Through a water bath, mesocrystals are obtained from the supersaturated solutions with well-faceted nucleation and growth. Different polymorphisms are induced with different ratios of enantiomers. And the dissolution rate for fabricating the API is enhanced.

Abstract: Disclosed herein is a method of lowering the sublimation point of a small-molecular organic semiconducting material. The method comprises the steps of forming a suspension solution of the small-molecular organic semiconducting material in a polar solvent, and sonicating the suspension solution with an ultrasound wave under low temperature.

Abstract: The present invention discloses an ibuprofen amine salt and the synthesis thereof, and more particularly an ibuprofen amine salt yielded by the neutralization reaction of a racemic mixture of ibuprofen with tris(hydroxymethyl)aminomethane in a solution system of water and an organic solvent. Compared with racemic mixtures of ibuprofen, the ibuprofen amine salt has higher solubility and a higher melting point, thereby having better bioavailability and properties than racemic mixtures of ibuprofen during pharmaceutical processing. Further, the ibuprofen amine salts of the present invention are stable between pH 4 and 9 so that they can be more widely applied to medicines.

Abstract: Disclosed are a method of treating cancer and/or other proliferative diseases comprising orally administering N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-1,3-thiazole-5-carboxamide or a salt thereof, and pharmaceutical compositions comprising N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-1,3-thiazole-5-carboxamide or a salt thereof. Also disclosed are N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-1,3-thiazole-5-carboxamide salts, as well as crystalline forms thereof.